5-HT receptor explained

5-HT receptors, 5-hydroxytryptamine receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems.[1] [2] [3] They mediate both excitatory and inhibitory neurotransmission. The serotonin (i.e., 5-hydroxytryptamine, hence "5-HT") receptors are activated by the neurotransmitter serotonin, which acts as their natural ligand.

The serotonin receptors modulate the release of many neurotransmitters, including glutamate, GABA, dopamine, epinephrine / norepinephrine, and acetylcholine, as well as many hormones, including oxytocin, prolactin, vasopressin, cortisol, corticotropin, and substance P, among others. Serotonin receptors influence various biological and neurological processes such as aggression, anxiety, appetite, cognition, learning, memory, mood, nausea, sleep, and thermoregulation. They are the target of a variety of pharmaceutical and recreational drugs, including many antidepressants, antipsychotics, anorectics, antiemetics, gastroprokinetic agents, antimigraine agents, hallucinogens, and entactogens.[4]

Serotonin receptors are found in almost all animals and are even known to regulate longevity and behavioral aging in the primitive nematode, Caenorhabditis elegans.[5] [6]

Classification

5-hydroxytryptamine receptors or 5-HT receptors, or serotonin receptors are found in the central and peripheral nervous systems.[1] [2] They can be divided into 7 families of G protein-coupled receptors which activate an intracellular second messenger cascade to produce an excitatory or inhibitory response. The exception to this is the 5-HT3 receptor which is a ligand-gated ion channel. In 2014, a novel 5-HT receptor was isolated from the small white butterfly, Pieris rapae, and named pr5-HT8. It does not occur in mammals and shares relatively low similarity to the known 5-HT receptor classes.[7]

Families

Family Type Mechanism Potential - 5-HT1 Gi/Go-protein coupled. Decreasing cellular levels of cAMP. Inhibitory - 5-HT2 Gq/G11-protein coupled. Increasing cellular levels of IP3 and DAG. Excitatory - 5-HT3 Ligand-gated Na+ and K+ cation channel. Depolarizing plasma membrane. Excitatory - 5-HT4 Gs-protein coupled. Increasing cellular levels of cAMP. Excitatory - 5-HT5 Gi/Go-protein coupled.[8] Decreasing cellular levels of cAMP. Inhibitory - 5-HT6 Gs-protein coupled. Increasing cellular levels of cAMP. Excitatory - 5-HT7 Gs-protein coupled. Increasing cellular levels of cAMP. Excitatory -

Subtypes

The 7 general serotonin receptor classes include a total of 14 known serotonin receptors.[9] The 15th receptor 5-HT1P has been distinguished on the basis of functional and radioligand binding studies, its existence has never been definitely affirmed or refuted.[10] [11] The specific types have been characterized as follows:[12] [13] [14]

Information on serotonin receptors (human isoforms if nothing else is stated)
ReceptorFirst clonedPDB entriesGene(s)DistributionFunctionAgonistsAntagonistsUses of drugs that act on this receptor
Blood vesselsCNSGI TractPlateletsPNSSmooth Muscle
5-HT1A1987 –
  • 7e2x
  • 7e2y
  • 7e2z
Selective (for 5-HT1A over other 5-HT receptors) Nonselective
  • Analgesics (agonists)
  • Antidepressants (post-synaptic receptor agonists and pre-synaptic autoreceptor antagonists serve as antidepressants)
  • Anxiolytics[41] (agonist and antagonist)
5-HT1B1992 –
  • 6g79
5-HT1D1991 –
  • 7e32
5-HT1E1992 –
  • 7e33
  • None known
5-HT1F1993 –
  • 7exd
  • Migraine
  • None known
5-HT1PNot cloned
  • 5-HTP-DP
  • None known
5-HT2A1988
  • Addiction (potentially modulating)[54]
  • Anxiety[55]
  • Appetite
  • Cognition
  • Imagination
  • Learning
  • Memory
  • Mood
  • Perception
  • Sexual Behavior[56]
  • Sleep[57]
  • Thermoregulation[58]
  • Vasoconstriction[59]
5-HT2B1992
5-HT2C1988
5-HT31993
  • Addiction
  • Anxiety
  • Emesis
  • GI Motility[77]
  • Learning[78]
  • Memory
  • Nausea
  • Antiemetic
  • Antidepressant (e.g., mirtazpine)
  • antipsychotic (e.g., olanzapine, quetiapine)
5-HT41995
5-HT5A1994
  • None thus far
5-HT5B1993Functions in rodents,
pseudogene in humans
  • None thus far
5-HT61993
  • Antidepressant (antagonists and agonists)
  • Anxiolytic (antagonists and agonist)
  • Nootropic (antagonists)
  • Anorectic (antagonists)
5-HT71993
  • Antidepressant (antagonists)
  • Anxiolytics (antagonists)
  • Nootropic (antagonists)

Note that there is no 5-HT1C receptor since, after the receptor was cloned and further characterized, it was found to have more in common with the 5-HT2 family of receptors and was redesignated as the 5-HT2C receptor.[107]

Very nonselective agonists of 5-HT receptor subtypes include ergotamine (an antimigraine), which activates 5-HT1A, 5-HT1D, 5-HT1B, D2 and norepinephrine receptors.[38] LSD (a psychedelic) is a 5-HT1A, 5-HT2A, 5-HT2C, 5-HT5A and 5-HT6 agonist.[38]

Expression patterns

The genes coding for serotonin receptors are expressed across the mammalian brain. Genes coding for different receptors types follow different developmental curves. Specifically, there is a developmental increase of HTR5A expression in several subregions of the human cortex, paralleled by a decreased expression of HTR1A from the embryonic period to the post-natal one.[108]

5-HT-like

A number of receptors were classed as "5-HT-like" - by 1998 it was being argued that, since these receptors were "a heterogeneous population of 5-HT1B, 5-HT1D and 5-HT7" receptors the classification was redundant.[109]

External links

Notes and References

  1. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP . 6 . International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) . Pharmacological Reviews . 46 . 2 . 157–203 . June 1994 . 7938165 .
  2. Book: Frazer A, Hensler JG . Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD . Basic Neurochemistry: MolecularCellular, and Medical Aspects . Lippincott-Raven . Philadelphia . 1999. 263–292. 978-0-397-51820-3 . Chapter 13: Serotonin Receptors . https://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=bnchm.section.963 .
  3. Beliveau V, Ganz M, Feng L, Ozenne B, Højgaard L, Fisher PM, Svarer C, Greve DN, Knudsen GM . 6 . A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System . The Journal of Neuroscience . 37 . 1 . 120–128 . January 2017 . 28053035 . 5214625 . 10.1523/jneurosci.2830-16.2016 .
  4. Nichols DE, Nichols CD . Serotonin receptors . Chemical Reviews . 108 . 5 . 1614–1641 . May 2008 . 18476671 . 10.1021/cr078224o .
  5. Murakami H, Murakami S . Serotonin receptors antagonistically modulate Caenorhabditis elegans longevity . Aging Cell . 6 . 4 . 483–488 . August 2007 . 17559503 . 10.1111/j.1474-9726.2007.00303.x . 8345654 . free .
  6. Murakami H, Bessinger K, Hellmann J, Murakami S . Manipulation of serotonin signal suppresses early phase of behavioral aging in Caenorhabditis elegans . Neurobiology of Aging . 29 . 7 . 1093–1100 . July 2008 . 17336425 . 10.1016/j.neurobiolaging.2007.01.013 . 37671716 .
  7. Qi YX, Xia RY, Wu YS, Stanley D, Huang J, Ye GY . Larvae of the small white butterfly, Pieris rapae, express a novel serotonin receptor . Journal of Neurochemistry . 131 . 6 . 767–777 . December 2014 . 25187179 . 10.1111/jnc.12940 . 21621635 .
  8. Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE . The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells . European Journal of Pharmacology . 361 . 2–3 . 299–309 . November 1998 . 9865521 . 10.1016/S0014-2999(98)00744-4 .
  9. Book: Malenka RC, Nestler EJ, Hyman SE . Sydor A, Brown RY . Molecular Neuropharmacology: A Foundation for Clinical Neuroscience . 2009 . McGraw-Hill Medical . New York . 9780071481274 . 4 . 2nd . Similarly, little is known about which of serotonin's 14 known receptors must be activated to achieve an antidepressant response. .
  10. Book: Brady ST . Basic Neurochemistry - Principles of Molecular, Cellular and Medical Neurobiology . USA: Elsevier . 2012 . 978-0-12-374947-5 . 8th . Waltham, MA . 320–321.
  11. Mitchell NA, Pepperell E, Ociepka S, Brown JD, Witherington J, Tuladhar B, Sanger GJ, Lee K, Cellek S . 6 . 5-hydroxyindalpine, an agonist at the putative 5-HT receptor, has no activity on human recombinant monoamine receptors but accelerates distension-induced peristalsis in mouse isolated colon . Neurogastroenterology and Motility . 21 . 7 . 760–e48 . July 2009 . 19309442 . 10.1111/j.1365-2982.2009.01275.x . 9532359 .
  12. Web site: Serotonin Receptor Subtypes and Ligands . 2008-04-11 . Glennon RA, Dukat M, Westkaemper RB . 2000-01-01 . American College of Neurophyscopharmacology . https://web.archive.org/web/20080421160353/http://www.acnp.org/g4/GN401000039/Ch039.html. 21 April 2008 . live.
  13. Web site: 5-Hydroxytryptamine Receptors . 2008-04-11 . IUPHAR Receptor Database . International Union of Basic and Clinical Pharmacology .
  14. Wesołowska A . In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors . Polish Journal of Pharmacology . 54 . 4 . 327–341 . 2002 . 12523486 .
  15. Tomkins DM, Higgins GA, Sellers EM . Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake . Psychopharmacology . 115 . 1–2 . 173–179 . June 1994 . 7862892 . 10.1007/BF02244769 . 38012716 .
  16. Müller CP, Carey RJ, Huston JP, De Souza Silva MA . Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors . Progress in Neurobiology . 81 . 3 . 133–178 . February 2007 . 17316955 . 10.1016/j.pneurobio.2007.01.001 . 42788995 .
  17. Carey RJ, DePalma G, Damianopoulos E, Shanahan A, Müller CP, Huston JP . Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects . Brain Research . 1034 . 1–2 . 162–171 . February 2005 . 15713268 . 10.1016/j.brainres.2004.12.012 . 28356741 .
  18. de Boer SF, Koolhaas JM . 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis . European Journal of Pharmacology . 526 . 1–3 . 125–139 . December 2005 . 16310183 . 10.1016/j.ejphar.2005.09.065 .
  19. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M . Increased anxiety of mice lacking the serotonin1A receptor . Proceedings of the National Academy of Sciences of the United States of America . 95 . 18 . 10734–10739 . September 1998 . 9724773 . 27964 . 10.1073/pnas.95.18.10734 . free . 1998PNAS...9510734P .
  20. Ebenezer IS, Arkle MJ, Tite RM . 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors . Methods and Findings in Experimental and Clinical Pharmacology . 29 . 4 . 269–272 . May 2007 . 17609739 . 10.1358/mf.2007.29.4.1075362 .
  21. Wouters W, Tulp MT, Bevan P . Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors . European Journal of Pharmacology . 149 . 3 . 213–223 . May 1988 . 2842163 . 10.1016/0014-2999(88)90651-6 .
  22. Horiuchi J, McDowall LM, Dampney RA . Role of 5-HT(1A) receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation . Autonomic Neuroscience . 142 . 1–2 . 71–76 . November 2008 . 18667366 . 10.1016/j.autneu.2008.06.004 . 20878941 .
  23. Nalivaiko E, Ootsuka Y, Blessing WW . Activation of 5-HT1A receptors in the medullary raphe reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits . American Journal of Physiology. Regulatory, Integrative and Comparative Physiology . 289 . 2 . R596–R604 . August 2005 . 15802554 . 10.1152/ajpregu.00845.2004 . 17426759 .
  24. Lucot JB . Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin . European Journal of Pharmacology . 253 . 1–2 . 53–60 . February 1994 . 8013549 . 10.1016/0014-2999(94)90756-0 .
  25. Winstanley CA, Theobald DE, Dalley JW, Robbins TW . Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders . Neuropsychopharmacology . 30 . 4 . 669–682 . April 2005 . 15688093 . 10.1038/sj.npp.1300610 . free .
  26. Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O . 6 . The role of 5-HT(1A) receptors in learning and memory . Behavioural Brain Research . 195 . 1 . 54–77 . December 2008 . 18394726 . 10.1016/j.bbr.2008.02.023 . 140205386 .
  27. Yasuno F, Suhara T, Nakayama T, Ichimiya T, Okubo Y, Takano A, Ando T, Inoue M, Maeda J, Suzuki K . 6 . Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory . The American Journal of Psychiatry . 160 . 2 . 334–340 . February 2003 . 12562581 . 10.1176/appi.ajp.160.2.334 .
  28. Kennett GA, Dourish CT, Curzon G . Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression . European Journal of Pharmacology . 134 . 3 . 265–274 . February 1987 . 2883013 . 10.1016/0014-2999(87)90357-8 .
  29. Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC . Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain . Pharmacology . 67 . 4 . 182–194 . April 2003 . 12595749 . 10.1159/000068404 . 25882138 .
  30. Millan MJ, Perrin-Monneyron S . Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors . European Journal of Pharmacology . 321 . 3 . R11–R13 . March 1997 . 9085055 . 10.1016/S0014-2999(97)00050-2 .
  31. Prow MR, Martin KF, Heal DJ . 8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation . European Journal of Pharmacology . 317 . 1 . 21–28 . December 1996 . 8982715 . 10.1016/S0014-2999(96)00693-0 .
  32. Meyer LC, Fuller A, Mitchell D . Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats . American Journal of Physiology. Regulatory, Integrative and Comparative Physiology . 290 . 2 . R405–R413 . February 2006 . 16166206 . 10.1152/ajpregu.00440.2005 . 224414 .
  33. Popova NK, Amstislavskaya TG . Involvement of the 5-HT(1A) and 5-HT(1B) serotonergic receptor subtypes in sexual arousal in male mice . Psychoneuroendocrinology . 27 . 5 . 609–618 . July 2002 . 11965359 . 10.1016/S0306-4530(01)00097-X . 25269315 .
  34. Monti JM, Jantos H . Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat . Journal of Sleep Research . 1 . 3 . 169–175 . September 1992 . 10607047 . 10.1111/j.1365-2869.1992.tb00033.x . free .
  35. Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS . A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy") . Neuroscience . 146 . 2 . 509–514 . May 2007 . 17383105 . 10.1016/j.neuroscience.2007.02.032 . 15617471 .
  36. Gudelsky GA, Koenig JI, Meltzer HY . Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors . Neuropharmacology . 25 . 12 . 1307–1313 . December 1986 . 2951611 . 10.1016/0028-3908(86)90101-2 . 2547042 .
  37. Ootsuka Y, Blessing WW . Activation of 5-HT1A receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits . Brain Research . 1073-1074 . 252–261 . February 2006 . 16455061 . 10.1016/j.brainres.2005.12.031 . 23178233 .
  38. http://pharmacologycorner.com/serotonin-5ht-receptors-agonists-antagonist/ Pharmacology Corner > Serotonin (5-HT): receptors, agonists and antagonists
  39. "BRINTELLIX (vortioxetine) tablets for oral use. Full Prescribing Information, Section 12.2 (Pharmacodynamics)." Takeda Pharmaceuticals America Inc. and Lundbeck, 2013. Revised September 2013. http://general.takedapharm.com/content/file/pi.pdf?applicationcode=396066C6-E50F-4113-ABAD-54FE9525BF7E&filetypecode=BRINTELLIXPI
  40. Saxena PR, Lawang A . A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors . Archives Internationales de Pharmacodynamie et de Therapie . 277 . 2 . 235–252 . October 1985 . 2933009 .
  41. Cao BJ, Rodgers RJ . Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice . Psychopharmacology . 139 . 3 . 185–194 . October 1998 . 9784072 . 10.1007/s002130050703 . 9466299 .
  42. Harrison AA, Parsons LH, Koob GF, Markou A . RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist . Psychopharmacology . 141 . 3 . 242–250 . January 1999 . 10027505 . 10.1007/s002130050831 . 19974789 .
  43. Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E . The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action . The Journal of Pharmacy and Pharmacology . 57 . 2 . 253–257 . February 2005 . 15720791 . 10.1211/0022357055399 . 20743875 .
  44. Lin D, Parsons LH . Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze . Pharmacology, Biochemistry, and Behavior . 71 . 4 . 581–587 . April 2002 . 11888549 . 10.1016/S0091-3057(01)00712-2 . 21610537 .
  45. Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E . Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression . Behavioural Pharmacology . 15 . 8 . 523–534 . December 2004 . 15577451 . 10.1097/00008877-200412000-00001 . 6940756 .
  46. Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO . Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission . Neuropharmacology . 54 . 7 . 1041–1050 . June 2008 . 18394658 . 10.1016/j.neuropharm.2008.02.007 . 207223573 . 10616/40922 .
  47. McCreary AC, Bankson MG, Cunningham KA . Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors . The Journal of Pharmacology and Experimental Therapeutics . 290 . 3 . 965–973 . September 1999 . 10454466 .
  48. Amital D, Fostick L, Sasson Y, Kindler S, Amital H, Zohar J . Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study . European Neuropsychopharmacology . 15 . 3 . 279–282 . May 2005 . 15820416 . 10.1016/j.euroneuro.2004.12.002 . 8382188 .
  49. Feuerstein TJ, Hüring H, van Velthoven V, Lücking CH, Landwehrmeyer GB . 5-HT1D-like receptors inhibit the release of endogenously formed [3H]GABA in human, but not in rabbit, neocortex . Neuroscience Letters . 209 . 3 . 210–214 . May 1996 . 8736648 . 10.1016/0304-3940(96)12637-9 . 27376524 . Bernhard Landwehrmeyer .
  50. Najjar SA, Hung LY, Margolis KG . Serotonergic Control of Gastrointestinal Development, Motility, and Inflammation . Comprehensive Physiology . 13 . 3 . 4851–4868 . June 2023 . 37358510 . 10.1002/cphy.c220024 . 10373054 . 9780470650714 .
  51. Branchek TA, Mawe GM, Gershon MD . Characterization and localization of a peripheral neural 5-hydroxytryptamine receptor subtype (5-HT1P) with a selective agonist, 3H-5-hydroxyindalpine . The Journal of Neuroscience . 8 . 7 . 2582–2595 . July 1988 . 3249244 . 6569501 . 10.1523/JNEUROSCI.08-07-02582.1988 .
  52. Mawe GM, Branchek TA, Gershon MD . Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists . Proceedings of the National Academy of Sciences of the United States of America . 83 . 24 . 9799–9803 . December 1986 . 3467338 . 387229 . 10.1073/pnas.83.24.9799 . free . 1986PNAS...83.9799M .
  53. Annaházi . Anita . Berger . Thomas Erwin . Demir . Ihsan Ekin . Zeller . Florian . Müller . Michael . Anneser . Markus . Skerra . Arne . Michel . Klaus . Schemann . Michael . April 2022 . Metabotropic 5-HT receptor-mediated effects in the human submucous plexus . Neurogastroenterology & Motility . en . 34 . 10 . e14380 . 10.1111/nmo.14380 . 35438222 . 248241342 . 1350-1925. free .
  54. Bubar MJ, Cunningham KA . Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence . Current Topics in Medicinal Chemistry . 6 . 18 . 1971–1985 . 2006 . 17017968 . 10.2174/156802606778522131 .
  55. Schreiber R, Melon C, De Vry J . The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test . Psychopharmacology . 135 . 4 . 383–391 . February 1998 . 9539263 . 10.1007/s002130050526 . 22677071 .
  56. Popova NK, Amstislavskaya TG . 5-HT2A and 5-HT2C serotonin receptors differentially modulate mouse sexual arousal and the hypothalamo-pituitary-testicular response to the presence of a female . Neuroendocrinology . 76 . 1 . 28–34 . July 2002 . 12097814 . 10.1159/000063681 . 42319246 .
  57. Popa D, Léna C, Fabre V, Prenat C, Gingrich J, Escourrou P, Hamon M, Adrien J . 6 . Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors . The Journal of Neuroscience . 25 . 49 . 11231–11238 . December 2005 . 16339018 . 6725907 . 10.1523/JNEUROSCI.1724-05.2005 .
  58. Mazzola-Pomietto P, Aulakh CS, Tolliver T, Murphy DL . Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists . Psychopharmacology . 130 . 2 . 144–151 . March 1997 . 9106912 . 10.1007/s002130050222 . 22432569 .
  59. Blessing WW, Seaman B . 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats . Neuroscience . 117 . 4 . 939–948 . 2003 . 12654345 . 10.1016/S0306-4522(02)00810-2 . 53251590 .
  60. McCall RB, Franklin SR, Hyslop DK, Knauer CS, Chio CL, Haber CL, Fitzgerald LW . PNU-22394, a 5-HT2C receptor agonist, reduced feeding in rodents and produces weight loss in humans . 2001 . Society for Neuroscience . Presentation Number 309.2 . 27 . 309.2 . Society for Neuroscience Abstracts . TT-45. San Diego, CA . Online . 18 July 2014.
  61. Garfield AS, Heisler LK . Pharmacological targeting of the serotonergic system for the treatment of obesity . The Journal of Physiology . 587 . 1 . 49–60 . January 2009 . 19029184 . 2670022 . 10.1113/jphysiol.2008.164152 .
  62. Jensen AA, Plath N, Pedersen MH, Isberg V, Krall J, Wellendorph P, Stensbøl TB, Gloriam DE, Krogsgaard-Larsen P, Frølund B . 6 . Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties . Journal of Medicinal Chemistry . 56 . 3 . 1211–1227 . February 2013 . 23301527 . 10.1021/jm301656h . 10.1.1.691.154 .
  63. Kennett GA, Bright F, Trail B, Baxter GS, Blackburn TP . Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety . British Journal of Pharmacology . 117 . 7 . 1443–1448 . April 1996 . 8730737 . 1909458 . 10.1111/j.1476-5381.1996.tb15304.x .
  64. Duxon MS, Kennett GA, Lightowler S, Blackburn TP, Fone KC . Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat . Neuropharmacology . 36 . 4–5 . 601–608 . 1997 . 9225285 . 10.1016/S0028-3908(97)00042-7 . 41471226 .
  65. Kennett GA, Trail B, Bright F . Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated . Neuropharmacology . 37 . 12 . 1603–1610 . December 1998 . 9886683 . 10.1016/S0028-3908(98)00115-4 . 7310462 .
  66. Kennett GA, Ainsworth K, Trail B, Blackburn TP . BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats . Neuropharmacology . 36 . 2 . 233–239 . February 1997 . 9144661 . 10.1016/S0028-3908(96)00171-2 . 23583570 .
  67. Borman RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL, Carey J, Coleman RA, Baxter GS . 6 . 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro . British Journal of Pharmacology . 135 . 5 . 1144–1151 . March 2002 . 11877320 . 1573235 . 10.1038/sj.bjp.0704571 .
  68. Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP . 6 . SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist . Neuropharmacology . 36 . 4–5 . 609–620 . 1997 . 9225286 . 10.1016/S0028-3908(97)00038-5 . 23032157 .
  69. Millan MJ, Brocco M, Gobert A, Dekeyne A . Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade . Psychopharmacology . 177 . 4 . 448–458 . February 2005 . 15289999 . 10.1007/s00213-004-1962-z . 20866665 .
  70. Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ . 6 . S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models . Psychopharmacology . 199 . 4 . 549–568 . September 2008 . 18523738 . 10.1007/s00213-008-1177-9 . 25063495 .
  71. Fujitsuka N, Asakawa A, Hayashi M, Sameshima M, Amitani H, Kojima S, Fujimiya M, Inui A . 6 . Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin . Biological Psychiatry . 65 . 9 . 748–759 . May 2009 . 19058784 . 10.1016/j.biopsych.2008.10.031 . 22053616 .
  72. Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S . 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists . European Journal of Pharmacology . 325 . 1 . 9–12 . April 1997 . 9151932 . 10.1016/S0014-2999(97)89962-1 .
  73. Stancampiano R, Melis MR, Argiolas A . Penile erection and yawning induced by 5-HT1C receptor agonists in male rats: relationship with dopaminergic and oxytocinergic transmission . European Journal of Pharmacology . 261 . 1–2 . 149–155 . August 1994 . 8001637 . 10.1016/0014-2999(94)90313-1 .
  74. Frank MG, Stryker MP, Tecott LH . Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor . Neuropsychopharmacology . 27 . 5 . 869–873 . November 2002 . 12431861 . 2452994 . 10.1016/S0893-133X(02)00353-6 .
  75. Villalobos CA, Bull P, Sáez P, Cassels BK, Huidobro-Toro JP . 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes . British Journal of Pharmacology . 141 . 7 . 1167–1174 . April 2004 . 15006903 . 1574890 . 10.1038/sj.bjp.0705722 .
  76. Book: Rang HP . Pharmacology . Churchill Livingstone . Edinburgh . 2003 . 978-0-443-07145-4 . Page 187
  77. Michel K, Zeller F, Langer R, Nekarda H, Kruger D, Dover TJ, Brady CA, Barnes NM, Schemann M . 6 . Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors . Gastroenterology . 128 . 5 . 1317–1326 . May 2005 . 15887114 . 10.1053/j.gastro.2005.02.005 . free .
  78. Pitsikas N, Brambilla A, Borsini F . Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task . Pharmacology, Biochemistry, and Behavior . 47 . 1 . 95–99 . January 1994 . 8115433 . 10.1016/0091-3057(94)90116-3 . 21800364 .
  79. Smriga M, Torii K . L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats . Proceedings of the National Academy of Sciences of the United States of America . 100 . 26 . 15370–15375 . December 2003 . 14676321 . 307574 . 10.1073/pnas.2436556100 . free . 2003PNAS..10015370S .
  80. Kennett GA, Bright F, Trail B, Blackburn TP, Sanger GJ . Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats . Neuropharmacology . 36 . 4–5 . 707–712 . 1997 . 9225297 . 10.1016/S0028-3908(97)00037-3 . 40341646 .
  81. Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V . 6 . Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens . Proceedings of the National Academy of Sciences of the United States of America . 104 . 41 . 16335–16340 . October 2007 . 17913892 . 2042207 . 10.1073/pnas.0701471104 . free . 2007PNAS..10416335J .
  82. Compan V, Charnay Y, Dusticier N, Daszuta A, Hen R, Bockaert J . [Feeding disorders in 5-HT4 receptor knockout mice] . Journal de la Société de Biologie . 198 . 1 . 37–49 . 2004 . 15146954 . 10.1051/jbio/2004198010037 . 90408378 .
  83. Meneses A, Hong E . Effects of 5-HT4 receptor agonists and antagonists in learning . Pharmacology, Biochemistry, and Behavior . 56 . 3 . 347–351 . March 1997 . 9077568 . 10.1016/S0091-3057(96)00224-9 . 11866740 .
  84. Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM . The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation . Neuropharmacology . 36 . 4–5 . 689–696 . 1997 . 9225295 . 10.1016/S0028-3908(97)00055-5 . 46510811 .
  85. Galeotti N, Ghelardini C, Bartolini A . Role of 5-HT4 receptors in the mouse passive avoidance test . The Journal of Pharmacology and Experimental Therapeutics . 286 . 3 . 1115–1121 . September 1998 . 9732367 .
  86. Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Piñeyro G, Sadikot AF, Debonnel G . 6 . Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action . Neuron . 55 . 5 . 712–725 . September 2007 . 17785179 . 10.1016/j.neuron.2007.07.041 . 14558104 . free .
  87. Duman RS . A silver bullet for the treatment of depression? . Neuron . 55 . 5 . 679–681 . September 2007 . 17785173 . 10.1016/j.neuron.2007.08.011 . free .
  88. Manzke T, Guenther U, Ponimaskin EG, Haller M, Dutschmann M, Schwarzacher S, Richter DW . 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia . Science . 301 . 5630 . 226–229 . July 2003 . 12855812 . 10.1126/science.1084674 . 13641423 . 2003Sci...301..226M .
  89. Nelson DL . 5-HT5 receptors . Current Drug Targets. CNS and Neurological Disorders . 3 . 1 . 53–58 . February 2004 . 14965244 . 10.2174/1568007043482606 .
  90. Dietz BM, Mahady GB, Pauli GF, Farnsworth NR . Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro . Brain Research. Molecular Brain Research . 138 . 2 . 191–197 . August 2005 . 15921820 . 5805132 . 10.1016/j.molbrainres.2005.04.009 .
  91. Zhang S, Chen H, Zhang C, Yang Y, Popov P, Liu J, Krumm BE, Cao C, Kim K, Xiong Y, Katritch V, Shoichet BK, Jin J, Fay JF, Roth BL . 6 . Inactive and active state structures template selective tools for the human 5-HT5A receptor . Nature Structural & Molecular Biology . 29 . 7 . 677–687 . July 2022 . 35835867 . 9299520 . 10.1038/s41594-022-00796-6 .
  92. Wesołowska A . The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors . European Journal of Pharmacology . 580 . 3 . 355–360 . February 2008 . 18096153 . 10.1016/j.ejphar.2007.11.022 .
  93. Wesołowska A, Nikiforuk A . Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression . Neuropharmacology . 52 . 5 . 1274–1283 . April 2007 . 17320917 . 10.1016/j.neuropharm.2007.01.007 . 22664564 .
  94. Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N . 6 . SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models . European Journal of Pharmacology . 553 . 1–3 . 109–119 . December 2006 . 17069795 . 10.1016/j.ejphar.2006.09.049 .
  95. Perez-García G, Meneses A . Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task . Pharmacology, Biochemistry, and Behavior . 81 . 3 . 673–682 . July 2005 . 15964617 . 10.1016/j.pbb.2005.05.005 . 19789219 .
  96. Wesołowska A, Nikiforuk A . The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats . European Journal of Pharmacology . 582 . 1–3 . 88–93 . March 2008 . 18234190 . 10.1016/j.ejphar.2007.12.013 .
  97. Alcalde E, Mesquida N, López-Pérez S, Frigola J, Mercè R . Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists . Journal of Medicinal Chemistry . 52 . 3 . 675–87 . Feb 2009 . 19159187 . 10.1021/jm8009469 .
  98. Web site: Target Schizophrenia - Possible future developments . 2008-04-11 . The Association of the British Pharmaceutical Industry . https://web.archive.org/web/20080612135635/http://www.abpi.org.uk/publications/publication_details/targetSchizophrenia-2003/section5.asp . 2008-06-12 . dead .
  99. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG . 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern . Biological Psychiatry . 58 . 10 . 831–837 . November 2005 . 16018977 . 10.1016/j.biopsych.2005.05.012 . 10998014 .
  100. Wesołowska A, Nikiforuk A, Stachowicz K, Tatarczyńska E . Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression . Neuropharmacology . 51 . 3 . 578–586 . September 2006 . 16828124 . 10.1016/j.neuropharm.2006.04.017 . 39928418 .
  101. Gasbarri A, Cifariello A, Pompili A, Meneses A . Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat . Behavioural Brain Research . 195 . 1 . 164–170 . December 2008 . 18308404 . 10.1016/j.bbr.2007.12.020 . 12910296 .
  102. Liy-Salmeron G, Meneses A . Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model . Hippocampus . 18 . 9 . 965–974 . 2008 . 18570192 . 10.1002/hipo.20459 . 20937527 .
  103. Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C . 6 . Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents . The Journal of Pharmacology and Experimental Therapeutics . 321 . 2 . 690–698 . May 2007 . 17314195 . 10.1124/jpet.107.119404 . 14579645 .
  104. Thomas DR, Melotto S, Massagrande M, Gribble AD, Jeffrey P, Stevens AJ, Deeks NJ, Eddershaw PJ, Fenwick SH, Riley G, Stean T, Scott CM, Hill MJ, Middlemiss DN, Hagan JJ, Price GW, Forbes IT . 6 . SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats . British Journal of Pharmacology . 139 . 4 . 705–714 . June 2003 . 12812993 . 1573887 . 10.1038/sj.bjp.0705290 .
  105. León-Ponte . Matilde . Ahern . Gerard P. . O'Connell . Peta J. . 2007-04-15 . Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor . Blood . en . 109 . 8 . 3139–3146 . 10.1182/blood-2006-10-052787 . 0006-4971 . 1852236 . 17158224.
  106. Davies MA, Sheffler DJ, Roth BL. Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology. CNS Drug Reviews [Internet]. 2004 [cited 2013 Aug 4];10(4):317–36. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2004.tb00030.x/pdf
  107. Web site: HTR2C 5-hydroxytryptamine receptor 2C [Homo sapiens (human) ] ]. 19 Mar 2017 . NCBI . 26 Mar 2017.
  108. Bar-Shira O, Maor R, Chechik G . Gene Expression Switching of Receptor Subunits in Human Brain Development . PLOS Computational Biology . 11 . 12 . e1004559 . December 2015 . 26636753 . 4670163 . 10.1371/journal.pcbi.1004559 . 2015PLSCB..11E4559B . free .
  109. Saxena PR, De Vries P, Villalón CM . 5-HT1-like receptors: a time to bid goodbye . Trends in Pharmacological Sciences . 19 . 8 . 311–316 . August 1998 . 9745358 . 10.1016/S0165-6147(98)01228-0 .